Enrique Cervantes-Pérez

Prof. Dr. Enrique Cervantes-Pérez

Internal Medicine, Hospital Civil de Guadalajara, Guadalajara, Jalisco, Mexico
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2022 in The Lancet
Verified
Journal Article
Open access
AAAaron B Andoh
Aaron B Andoh
AFAbantanga Atindaana Francis
Abantanga Atindaana Francis
AAAbdulhafiz A Abdulkarim
Abdulhafiz A Abdulkarim
AAAbdulhafiz O Adesunkanmi
Abdulhafiz O Adesunkanmi
ASAbdulkadir A Salako
Abdulkadir A Salako
ZRZelda Robertson
Zelda Robertson
Surgical site infection (SSI) remains the most common complication of surgery around the world. WHO does not make recommendations for changing gloves and instruments before wound closure owing to a lack of evidence. This study aimed to test whether a routine change of gloves and instruments before wound closure reduced abdominal SSI. ChEETAh was a multicentre, cluster randomised trial in seven low-income and middle-income countries (Benin, Ghana, India, Mexico, Nigeria, Rwanda, South Africa). Any hospitals (clusters) doing abdominal surgery in participating countries were eligible. Clusters were randomly assigned to current practice (42) versus intervention (39; routine change of gloves and instruments before wound closure for the whole scrub team). Consecutive adults and children undergoing emergency or elective abdominal surgery (excluding caesarean section) for a clean-contaminated, contaminated, or dirty operation within each cluster were identified and included. It was not possible to mask the site investigators, nor the outcome assessors, but patients were masked to the treatment allocation. The primary outcome was SSI within 30 days after surgery (participant-level), assessed by US Centers for Disease Control and Prevention criteria and on the basis of the intention-to-treat principle. The trial has 90% power to detect a minimum reduction in the primary outcome from 16% to 12%, requiring 12 800 participants from at least 64 clusters. The trial was registered with ClinicalTrials.gov, NCT03700749. Between June 24, 2020 and March 31, 2022, 81 clusters were randomly assigned, which included a total of 13 301 consecutive patients (7157 to current practice and 6144 to intervention group). Overall, 11 825 (88·9%) of 13 301 patients were adults, 6125 (46·0%) of 13 301 underwent elective surgery, and 8086 (60·8%) of 13 301 underwent surgery that was clean-contaminated or 5215 (39·2%) of 13 301 underwent surgery that was contaminated-dirty. Glove and instrument change took place in 58 (0·8%) of 7157 patients in the current practice group and 6044 (98·3%) of 6144 patients in the intervention group. The SSI rate was 1280 (18·9%) of 6768 in the current practice group versus 931 (16·0%) of 5789 in the intervention group (adjusted risk ratio: 0·87, 95% CI 0·79-0·95; p=0·0032). There was no evidence to suggest heterogeneity of effect across any of the prespecified subgroup analyses. We did not anticipate or collect any specific data on serious adverse events. This trial showed a robust benefit to routinely changing gloves and instruments before abdominal wound closure. We suggest that it should be widely implemented into surgical practice around the world. National Institute for Health Research (NIHR) Clinician Scientist Award, NIHR Global Health Research Unit Grant, Mölnlycke Healthcare.

4 November 2020 in International Journal of Mental Health and Addiction
Verified
Journal Article
Open access
PDF file
BGBenjamín García-Reyna
Benjamín García-Reyna
GCGilberto Daniel Castillo-García
Gilberto Daniel Castillo-García
FBFrancisco José Barbosa-Camacho
Francisco José Barbosa-Camacho
GCGuillermo Alonso Cervantes-Cardona
Guillermo Alonso Cervantes-Cardona
Enrique Cervantes-PérezEnrique Cervantes-Pérez
Enrique Cervantes-Pérez
GCGabino Cervantes-Guevara
Gabino Cervantes-Guevara
The presence of COVID-19 has had psychological consequences among health personnel; these include fear, anxiety, and depression. In the current study, we used the Fear of COVID-19 Scale (FCV-19S) to assess the response to fear within health staff in Mexico. This was a cross-sectional survey study in which we administered the Spanish version of the FCV-19S to hospital staff. The FCV-19S is a seven-item questionnaire that assesses the severity of fear caused by COVID-19. A total of 2860 participants—1641 female and 1218 male personnel from three hospitals—were included in the study. The internal reliability of the scale was good, with Cronbach’s alpha of .902. A confirmatory factor analysis (CFA) was conducted on the seven items of the FCV-19S, showing good model fit (χ2 (7) = 29.40, p < .001; CFI = .99; TLI = .99; RMSEA = .03; SRMR = .010; AIC = 71.40). We found a global FCV-19S mean score of 19.3 ± 6.9, with a significant difference in scores between women and men. Our survey shows a significantly higher level of fear in nursing and administrative personnel, which may be explained by the nursing staff being in close contact with infected patients and the administrative staff lacking understanding of the possible implications of the infection, compared with nonclinical hospital personnel. Our results are consistent with those of other researchers. We must remember that fear is a reaction and that we must be courageous enough to trust validated infection prevention practices to provide the highest standard of care, in the safest environment that we can, for as long as we can.

18 August 2020 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MSMarcela Salazar‐Parra
Marcela Salazar‐Parra
BGBertha Georgina Guzman‐Ramirez
Bertha Georgina Guzman‐Ramirez
KPKevin Josue Pintor‐Belmontes
Kevin Josue Pintor‐Belmontes
FBFrancisco José Barbosa‐Camacho
Francisco José Barbosa‐Camacho
ABAldo Bernal‐Hernández
Aldo Bernal‐Hernández
AGAlejandro González-Ojeda
Alejandro González-Ojeda

3 November 2021 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
GMGuillermo Medina‐Diaz‐Cortés
Guillermo Medina‐Diaz‐Cortés
IBIrma Valeria Brancaccio‐Pérez
Irma Valeria Brancaccio‐Pérez
IEIsaac Esparza‐Estrada
Isaac Esparza‐Estrada
FBFrancisco José Barbosa‐Camacho
Francisco José Barbosa‐Camacho
CFClotilde Fuentes‐Orozco
Clotilde Fuentes‐Orozco
AGAlejandro González-Ojeda
Alejandro González-Ojeda

14 November 2018 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
JCJonathan Samuel Chávez-Iñiguez
Jonathan Samuel Chávez-Iñiguez
RMRamón Medina-Gonzalez
Ramón Medina-Gonzalez
LALilia Aguilar-Parra
Lilia Aguilar-Parra
ETEduardo J. Torres-Vázquez
Eduardo J. Torres-Vázquez
PAPablo Maggiani Aguilera
Pablo Maggiani Aguilera
Guillermo Garcia-GarciaGuillermo Garcia-Garcia
Guillermo Garcia-Garcia
Acyclovir is one of the most common prescribed antiviral drugs. Acyclovir nephrotoxicity occurs in approximately 12–48% of cases. It can present in clinical practice as acute kidney injury (AKI), crystal-induced nephropathy, acute tubulointerstitial nephritis, and rarely, as tubular dysfunction. Electrolytes abnormalities like hypokalemia, were previously described only when given intravenously. A 54 year-old female presented with weakness and lower extremities paresis, nausea and vomiting after receiving oral acyclovir. Physical examination disclosed a decrease in the patellar osteotendinous reflexes (++ / ++++). Laboratory data showed a serum creatinine level of 2.1 mg/dL; serum potassium 2.1 mmol/L. Kidney biopsy was obtained; histological findings were consistent with acute tubular necrosis and acute tubulointerstitial nephritis. The patient was advised to stop the medications and to start with oral and intravenous potassium supplement, symptoms improved and continued until serum potassium levels were > 3.5 meq/L. The case reported in this vignette is unique since it is the first one to describe hypokalemia associated to acute tubular necrosis induced by oral acyclovir.

10 June 2020 in Research Square
Verified
Preprint
Open access
PDF file
BGBenjamín García-Reyna
Benjamín García-Reyna
GCGilberto Daniel Castillo-García
Gilberto Daniel Castillo-García
FCFrancisco José Barbosa Camacho
Francisco José Barbosa Camacho
GCGuillermo Alonso Cervantes-Cardona
Guillermo Alonso Cervantes-Cardona
Enrique Cervantes-PérezEnrique Cervantes-Pérez
Enrique Cervantes-Pérez
GCGabino Cervantes-Guevara
Gabino Cervantes-Guevara
The presence of COVID-19 has had psychological consequences among health personnel; these include fear, anxiety, and depression. In the current study, we used the Fear of COVID-19 Scale (FCV-19S) to assess the response to fear within health staff in Mexico. This was a cross-sectional survey study in which we administered the FCV-19S to hospital staff. A total of 2,860 participants—1,641 female and 1,218 male personnel from three hospitals—were included in the study. We found a global FCV-19S mean score of 19.3 ± 6.9, with a significant difference in scores for women and men. There was a high correlation between items 3, 5, 6, and 7, suggesting that these items could indicate the physiological responses to fear, and a high correlation between items 1, 2, and 4, suggesting these items could represent the emotional responses to fear. Our survey shows a significantly higher level of fear in nursing and administrative personnel, which may be explained by the nursing staff being in close contact with infected patients and the administrative staff lacking understanding of the possible implications of the infection, compared with non-clinical hospital personnel. The FCV-19S showed validity and reliability in our population to assess fear in response to COVID-19. Our results are consistent with those of other researchers.